10-Q: 22nd Century Group Q1 2026 Financials Show Revenue Decline

22nd Century Group reported a 31.1% decrease in net revenues for Q1 2026 compared to the prior year, primarily due to a strategic shift away from low-priced contract manufacturing export customers.

Summary

• Net revenues for the first quarter of 2026 were $4.1 million, a decrease of 31.1% from $6.0 million in the prior year period.
• This revenue decline is attributed to a strategic shift away from high-volume, low-priced contract manufacturing organization (CMO) export customers.
• Gross loss was $0.6 million for Q1 2026, slightly wider than the $0.6 million loss in Q1 2025.
• Total operating expenses increased to $2.4 million from $2.0 million in the prior year, driven by higher Sales, General & Administrative (SG&A) and Research & Development (R&D) expenses.
• Operating loss from continuing operations was $3.0 million, an increase from $2.6 million in the prior year.
• Net loss from continuing operations was $3.0 million, an improvement from $3.3 million in the prior year.
• The company had $9.5 million in cash and cash equivalents as of March 31, 2026.
• There is substantial doubt about the company's ability to continue as a going concern within one year.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as negative due to the significant revenue decline, increased operating expenses, and the continued substantial doubt about the company's ability to continue as a going concern, despite some improvements in net loss and cash position.

Positives

• Net loss from continuing operations improved to $3.0 million from $3.3 million in the prior year.
• Cash and cash equivalents increased to $9.5 million from $7.1 million at the end of the previous year.
• Working capital from continuing operations increased to $13.2 million from $10.4 million at the end of the previous year.
• Manufacturing overhead cost savings initiatives implemented in 2025 are benefiting gross loss.
• Interest expense significantly decreased due to debt repayment.
• The company received $200,000 in gross proceeds from its at-the-market (ATM) offering in Q1 2026.

Negatives

• Net revenues decreased by 31.1% to $4.1 million from $6.0 million in the prior year.
• Gross loss widened slightly to $0.6 million from $0.6 million, with gross loss as a percentage of revenue increasing from 10.2% to 15.5%.
• Total operating expenses increased by 22.5% to $2.4 million from $2.0 million.
• SG&A expenses increased by 17.7% to $2.1 million, and R&D expenses increased by 75.9% to $0.3 million.
• Operating loss from continuing operations increased by 18.2% to $3.0 million.
• There is substantial doubt about the company's ability to continue as a going concern.
• The company is actively pursuing financing strategies, including issuing debt or equity, to address its liquidity needs.

Risks

• Substantial doubt exists regarding the company's ability to continue as a going concern within one year.
• The company has incurred significant losses and negative cash flows from operations since inception and expects to continue doing so.
• Failure to secure additional capital could require liquidation of inventory, curtailment of operations, or seeking bankruptcy protection.
• Litigation risks include a breach of contract claim from Cookies Retail Products, LLC, and a premises liability/personal injury claim from a former employee related to a fire at a manufacturing facility.
• The company is subject to risks associated with the tobacco industry, including regulatory changes and market acceptance of its reduced nicotine products.
• The company's stock is subject to volatility, as indicated by the need for reverse stock splits to maintain Nasdaq listing.

Future Outlook

The company expects to incur additional losses until it can generate significant revenue and profit in its tobacco business. Management is evaluating strategies to reduce expenses and pursue financing, including debt or equity issuance, asset sales, and strategic partnerships. There is substantial doubt about the company's ability to continue as a going concern through one year following the issuance date of the financial statements.

Management Comments

• "Given the Companys projected operating requirements and its existing cash and cash equivalents, there is substantial doubt about the Companys ability to continue as a going concern through one year following the date that the Condensed Consolidated Financial Statements are issued."
• "In response to these conditions, management continues to evaluate different strategies for reducing expenses, as well as pursuing financing strategies which include raising additional funds through the issuance of debt or equity securities, asset sales, and through arrangements with strategic partners."
• "If capital is not available to the Company when, and in the amounts needed, it could be required to liquidate inventory, cease or curtail operations, or seek protection under applicable bankruptcy laws or similar state proceedings."
• "There can be no assurance that the Company will be able to raise the capital it needs to continue operations."

Industry Context

StockSavvy.ai notes that 22nd Century Group's Q1 2026 results reflect a challenging period for the tobacco industry, particularly for companies focused on innovative products like reduced nicotine cigarettes. The reported revenue decline and continued operating losses are common themes for companies undergoing strategic shifts or facing intense regulatory scrutiny. The company's focus on its FDA-authorized Modified Risk Tobacco Product (MRTP) remains a key differentiator, but its ability to scale and achieve profitability is heavily dependent on its success in securing further financing.

Comparison to Industry Standards

• The tobacco industry generally exhibits stable to declining volumes for traditional products, with growth concentrated in newer categories like e-cigarettes and reduced-risk products. 22nd Century Group's strategic shift away from low-margin CMO export customers aligns with a focus on higher-margin, proprietary products, a common strategy for differentiation.
• Companies in the tobacco sector often face significant regulatory hurdles and excise taxes, which are reflected in 22nd Century Group's cost of goods sold and excise tax expenses.
• The ongoing trend towards harm reduction and product innovation is a key industry driver. 22nd Century Group's VLN product, with its FDA MRTP authorization, positions it uniquely, but it competes with established players and emerging alternatives in the reduced-risk product space.
• The need for continuous capital raises is not uncommon for companies in the early stages of commercializing novel products in highly regulated industries, though the frequency and magnitude of these raises can be a concern for investors.

Legal Proceedings

• Cookies Retail Products, LLC filed a complaint alleging Breach of Contract, Fraud - False Promise, and Violation of Penal Code Section 496. The court granted the Company's Special Motion to Strike as to Count II and Count III, leaving only Count I. The trial date is set for October 27, 2026.
• A former employee filed a complaint alleging Premises Liability, Personal Injury - Employer Liability Law, and Negligence/Negligence Per Se related to a fire at the Grass Valley manufacturing facility. The company believes it has substantial defenses and intends to defend itself vigorously.

Stakeholder Impact

• Shareholders: The continued operating losses, substantial doubt about going concern, and need for capital raises may negatively impact shareholder value and dilute existing ownership through future equity issuances.
• Creditors: The company's liquidity challenges and going concern issues could impact its ability to meet debt obligations.
• Employees: Uncertainty about the company's future operations due to financial challenges could affect employee morale and job security.
• Suppliers: Potential financial distress could impact the company's ability to pay suppliers on time.

Next Steps

• Management will continue to evaluate strategies for reducing expenses.
• Management will pursue financing strategies, including issuing debt or equity securities, asset sales, and arrangements with strategic partners.
• The company will continue to defend itself in ongoing litigation.
• The company will continue to monitor and manage its liquidity and capital resources.

Key Dates

Recommendation

While the company faces significant financial challenges, including revenue decline and going concern doubts, the FDA authorization for its reduced nicotine product (VLN) and ongoing efforts to secure financing present potential upside. The current situation warrants a 'hold' recommendation, advising investors to monitor future financing developments and the company's ability to execute its strategic shift towards higher-margin products.

Keywords

22nd Century Group, 10-Q, Quarterly Report, Tobacco Products, Reduced Nicotine Cigarettes, VLN, Financial Results, Revenue Decline, Operating Loss, Going Concern, Capital Raise, FDA, Modified Risk Tobacco Product